Lamprini Galani INFECTIONS DISEASE SPECIALIST Assistant Director, 1st Internal Medicine & Infectious Diseases Department

• “Successful treatment of experimental aortic valve endocarditis with moxifloxacin due to methicillin-resistant Staphylococcus aureus (MRSA)”, 4th University dept. of Internal Medicine, University of Athens, November 2013

• Athens Medical Association
• Hellenic Society of Infectious Diseases
• Hellenic Society of Antimicrobial Chemotherapy
• Hellenic Association for the study and control of AIDS
• European Society of Clinical Microbiology and Infectious Diseases – ESCMID
• ESCMID Study Group for Infections in Critically Ill Patients – ESGCIP

• Attending physician in Internal Medicine & Infectious Diseases, 6th Department of Internal Medicine Hygeia Hospital, Athens, 2010 – present
• Attending physician, 4th Department of Internal Medicine Attikon University Hospital in Athens, active member of the stuff of the hospital’s HIV Unit, 2008-2009
• Infectious Diseases fellow, 4th University dept. of Internal Medicine, Attikon University Hospital in Athens, Greece, 2005-2008

Education Experience:

• Medical School of Athens: Physical Examination, Medical Diagnosis and Treatment in Internal Medicine (4th and 6th year students).
• Participation in the educational program for the exchange student of HELMSIC on HIV infection
• Residents’ Education: 4th Department of Internal Medicine, University of Athens on “Opportunistic infections in HIV infection”
• Lectures and advanced courses: on Infections as a guest of Scientific Societies and Associations.
• Teaching Seminars: for primary care physicians entitled “Infections and Antimicrobial Therapy in Primary Care” in various parts of Greece.
• Teaching Seminars: for clinician’s entitled “The Rational Use of Antibiotics by Hospital Doctor” in tertiary hospitals in Greece with the organization of the Greek Society of Chemotherapy.

Clinical Interest:

• Infections in pregnancy
• Nosocomial infections
• Infections in critically ill patients
• Infections from the community
• Infections in immunocompromised patients

Research Interest: 

• Epidemiology of nosocomial infections
• Therapy of resistant gram negative infections
• PK / PD of antibiotics
• Bacteremia
• Risk factors for colonization by multidrug resistant pathogens
• Antimicrobial resistance
• Surgical Site Infections
• Antibiotic stewardship

• First Award of Amfiaraeion Institute for Chemotherapy Studies, 40th PanHellenic Medical Congress, Athens, May 2014
• First Award of Amfiaraeion Institute for Chemotherapy Studies, 38th PanHellenic Medical Congress, Athens, May 2012
• Praise of Amfiaraeion Institute for Chemotherapy Studies, 37th PanHellenic Medical Congress, Athens, May 2011
• Praise of Amfiaraeion Institute for Chemotherapy Studies, Athens, May 2006
• Scholarship for 1 year on Infections: Amfiaraeion Institute for Chemotherapy (2004)

• Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013. Souli M, Karaiskos I, Galani L, et al. Infect Dis (Lond). 2015; 4:1-6
• Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients. Karaiskos I, Friberg LE, Pontikis K, Ioannidis K, Tsagkari V, Galani L, Kostakou E, Baziaka F, Paskalis C, Koutsoukou A, Giamarellou H. Antimicrob Agents Chemother. 2015 Dec; 59(12):7240-8. 
• Large vessel vasculitis in a patient with acute Q-fever: A case report. Baziaka F, Κaraiskos I, Galani L, Barmpouti E, Konstantinidis S, Kitas G, Giamarellou H. ID Cases. 2014, 1:56-9.
• Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece. Plachouras D, Antoniadou A, Giannitsioti E, Galani L, et al. BMC Public Health. 2014;14:866
• Nosocomial dissemination of Providencia stuartii isolates producing extended-spectrum β-lactamases VEB-1 and SHV-5, metallo-β-lactamase VIM-1, and RNA methylase RmtB. Galani L, Galani I, Souli M, Karaiskos I, Katsouda E, Patrozou E, Baziaka F, Paskalis C, Giamarellou H. Journal of Global Antimicrobial Resistance, 2013 June;1(2):115-116.
• Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. 
• Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, Paskalis H, Giamarellou H. Int J Antimicrob Agents.
  2013 May; 41(5):480-3
• Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Karaiskos I, Galani L, Baziaka F, Giamarellou H. Int J Antimicrob Agents. 2013 Jun;41(6):499-508
• Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
• Giamarellou H, Galani L, Baziaka F, Karaiskos I. Antimicrob Agents Chemother. 2013 May; 57(5):2388-90
• Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection. Papadopoulos AI, Ferwerda B, Antoniadou A, Sakka V, Galani L, Kavatha D, Panagopoulos P, Poulakou G, Protopapas K, van der Meer JW, Netea MG, Giamarellos-Bourboulis EJ. Cytokine. 2012 Oct;60(1):104-7
• Early changes of procalcitonin may advice about prognosis and appropriateness of antimicrobial therapy in sepsis. Georgopoulou AP, Savva A, Giamarellos-Bourboulis EJ, Georgitsi M, Raftogiannis M, Antonakos N, Apostolidou E, Carrer DP, Dimopoulos G, Economou A, Efthymiou G, Galanakis N, Galani L, et al. Hellenic Sepsis Study Group. J Crit Care. 2011 Jun;26(3):331.e1-7